What's new

Moderna refused China request to reveal vaccine technology

Hamartia Antidote

ELITE MEMBER
Joined
Nov 17, 2013
Messages
35,188
Reaction score
30
Country
United States
Location
United States

Oct 1 (Reuters) - Moderna Inc (MRNA.O) has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

Moderna did not immediately respond to Reuters' request for comment.

China has not approved any foreign COVID-19 vaccines and relies on several domestically developed shots.

In September, Moderna Chief Medical Officer Paul Burton had said the company was keen to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

"We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there," Burton had told a media briefing for reporters in Asia. "Currently, there is no activity going on, but we'd be very open to it."
 
. . .
Moderna might just have shut itself out of Chinese market forever
 
. . .

Oct 1 (Reuters) - Moderna Inc (MRNA.O) has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.

The Cambridge, Massachusetts-based pharmaceutical company turned down China’s request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns, the newspaper said, citing people involved in negotiations that took place between 2020 and 2021, adding that the vaccine maker is still “eager” to sell the product to China.

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

The company had “given up” on its previous efforts to access the Chinese market because of China’s demand that it hand over the technology as a prerequisite for selling in the country, the report said.

Moderna did not immediately respond to Reuters' request for comment.

China has not approved any foreign COVID-19 vaccines and relies on several domestically developed shots.

In September, Moderna Chief Medical Officer Paul Burton had said the company was keen to collaborate with China on supplying its mRNA-based COVID-19 vaccines to the country.

"We would certainly be very eager to collaborate with China if they felt that there was a need for a vaccine there," Burton had told a media briefing for reporters in Asia. "Currently, there is no activity going on, but we'd be very open to it."

only fit for copying and stealing
 
.
Why are they taking so long through ?

China has mRNA vaccines, but Chinese people do not trust mRNA vaccines. Therefore, the number of these vaccines sold in China is not large.


During the COVID epidemic, it was the first time that human beings used mRNA vaccine. These vaccines have not confirmed that they will not affect human body in the future. So we trust inactivated vaccine more. We are willing to wait and observe the results of large-scale use of mRNA vaccines in Western countries before making a decision.
 
.
Moderna might just have shut itself out of Chinese market forever

Better than going out of business when some Chinese company leverages their tech and under prices them in the world market since they would have no need to recoup any of the years of R&D expenses Moderna had to go through.

This is the typical strategy Chinese companies use to destroy foreign companies.
 
Last edited:
. .
Better than going out of business when some Chinese company leverages their tech and under prices them in the world market since they would have no need to recoup any of the years of R&D expenses Moderna had to go through.

This is the typical strategy Chinese companies use to destroy foreign companies.
If we really do what you said, the PAF is already using J11&J16.
 
.
If we really do what you said, the PAF is already using J11&J16.

Well the Russians are complaining about pretty much everything else


 
.
Well the Russians are complaining about pretty much everything else


At least we didn't sell copies to other countries as you said. All the flanks we make serve in China.
 
. .
Better than going out of business when some Chinese company leverages their tech and under prices them in the world market since they would have no need to recoup any of the years of R&D expenses Moderna had to go through.

This is the typical strategy Chinese companies use to destroy foreign companies.
Is that Tesla did, will they go out of business soon?
 
.
Back
Top Bottom